πŸ‡ΊπŸ‡Έ FDA
Patent

US 6051711

Synthesis of swainsonine salts

expired A61PA61P43/00

Quick answer

US patent 6051711 (Synthesis of swainsonine salts) held by GlycoDesign Holdings Ltd. expires Mon Apr 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
GlycoDesign Holdings Ltd.
Grant date
Tue Apr 18 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
53
CPC classes
A61P, A61P43/00